Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00166452
Status:
COMPLETED
Last Update Posted:
2011-03-23
First Post:
2005-09-12
Brief Title:
A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Multicenter Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if lenalidomide is a safe and effective treatment for complex regional pain syndrome type 1 CRPS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None